Conference Full Schedule

Opening Statements and Welcome

Vic Tackett, APRNA, CRNA - OANA President

*Let's Party! Old and New Psychoactive Substances - Scott Herring (*2)

• Identify examples of old and new psychoactive substances.
• Explain how to test for and identify the use of psychoactive
• Substances.
• Describe the anesthetic implications of psychoactive substances.

Break with Exhibitors

*Alpha-Gall Syndrome Identification and Risk Management in the Perioperative Setting - Shannon Noffsinger, DNAP, CRNA (*.5)

• Understand Alpha-Gal Syndrome (AGS) transmission, incidence, risk factors, and pathogenicity.
• Understand common triggers for AGS in the perioperative environment.
• Understand methods for identifying undiagnosed AGS in patients and be able to develop a safe anesthetic plan for this patient population through a discussion of current evidence and recent case studies.

AANA Update - Gregory Collins, DNP, CRNA

• Describe trends in AANA membership demographics, education, employment, and public relations.
• List the factors driving our national scope of activities.
• Explain the initiatives regarding CRNA Wellness, PAC, and research.

Noon - 1:00 p.m.

1:00 - 2:00 p.m.

Lunch with Exhibitors

OANA Update - Vic Tackett, APRNA, CRNA

• Explain the inception of the OANA and name the founders.
• State and describe three pivotal moments in OANA history.

GLP-1 Agonists: The case for POCUS Assessment of the Gastric Antrum - Gregory Collins, DNP, CRNA

• Illustrate the ubiquity and anesthetic implications of GLP-1 agonist therapy.
• Develop clinical decision-making tools regarding gastric contents.
• Demonstrate ultrasound recognition and assessment of gastric antrum.

*Medical Cannabis Science and Therapeutics - Mary Scott-Herring, DNP, MS, CRNA (*1)

• Identify the types and formulations of cannabis.
• Articulate the effects of cannabis and how to manage them.
• Describe indications for cannabis treatment.

4:00-5:00 p.m.

Student Presentations

*CRNAs as First Responders - Mary Scott-Herring, DNP, MS, CRNA (*.25)

• Explain the EMS system
• Compare skills sets/medication/equipment used
• Analyze the types of patients treated

:

*Neuraxial Dexmedetomidine: Help or Hype? - Gregory Collins, DNP, CRNA (*1)

• Review the pharmacology of dexmedetomidine.
• Consider the evidence regarding the safety and efficacy of neuraxial dexmedetomidine.
• Propose avenues to incorporate neuraxial dexmedetomidine into current practice.

Perioperative Uses for TXA - Shannon Noffsinger, DNAP, CRNA

• Understand the mechanism of action, pharmacology, and safety profile of TXA.in perioperative patient care.
• Analyze current evidence of TXA administration across surgical specialties, identifying uses backed by substantive data and areas where data remains equivocal.
• Integrate TXA administration into perioperative patient blood management strategies based on current evidence while tailored to surgical context and patient-specific factors.

11:00 a.m.-1:00 p.m. 

Student Presentations

Closing Remarks 

       Vic Tackett, CRNA, OANA President

Posters - 2 Hours of Instruction

Twenty poster sessions will be presented Saturday, 7:00 a.m.-Sunday, 10:00 a.m.